Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Chest
    July 2025
  1. BACKMAN H, Myrberg T, Hedman L, Stridsman C, et al
    Importance of Preserved Ratio Impaired Spirometry as a Risk Factor for Development of COPD, Also in Those Who Do Not Smoke.
    Chest. 2025;168:83-94.
    >> Share

  2. KALRA S, Hobbs B, Hunninghake GM, Menon AA, et al
    The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry With Mortality.
    Chest. 2025;168:136-145.
    >> Share

  3. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
    Chest. 2025;168:56-66.
    >> Share

    June 2025
  4. KIM H, Choi SH, Ryerson CJ, George PM, et al
    Combined Interstitial Features and Emphysema in National Lung Screening Trial Participants: Prognostic Implications.
    Chest. 2025 Jun 18:S0012-3692(25)00715-9. doi: 10.1016/j.chest.2025.
    >> Share

  5. ALTREE TJ, Pinczel AJ, Toson B, Loffler KA, et al
    The Effects of Low-Dose Morphine on Sleep and Breathlessness in COPD: A Randomized Trial.
    Chest. 2025;167:1578-1590.
    >> Share

    May 2025
  6. SERAJEDDINI H, Thakar A, Kjarsgaard M, Huang C, et al
    Sputum Cellularity and MRI Ventilation Defects in Severe Asthma.
    Chest. 2025 May 20:S0012-3692(25)00648-8. doi: 10.1016/j.chest.2025.
    >> Share

  7. YADAV CP, Chakraborty A, Price DB, Mien Lim LH, et al
    Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.
    Chest. 2025 May 19:S0012-3692(25)00647-6. doi: 10.1016/j.chest.2025.
    >> Share

  8. YILMAZ I, Turk M
    Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma.
    Chest. 2025;167:e167.
    >> Share

  9. CELLI BR, Anzueto A, Singh D, Hanania NA, et al
    The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD.
    Chest. 2025;167:1346-1355.
    >> Share

  10. FENG Z, Li G, He Q, Sun N, et al
    Associations of Socioeconomic Status and Phenotypic Frailty With Incident COPD: Findings From UK Biobank Participants.
    Chest. 2025;167:1321-1332.
    >> Share

    April 2025
  11. PELAIA G, Jackson DJ, Nair P, Emmanuel B, et al
    XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma.
    Chest. 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.
    >> Share

  12. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    >> Share

  13. HATANO H, Akamatsu T, Shirai T
    Considerations on Potential Overestimation of Asthma Prevalence.
    Chest. 2025;167:e141.
    >> Share

  14. KHOO YK, Kor AC, Lee CH
    Advancing Lung Ultrasound: Development and Application of the Lung Curtain Swing vs Time Graph in Assessing Asthma Exacerbation.
    Chest. 2025;167:e127-e131.
    >> Share

  15. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma.
    Chest. 2025;167:943-944.
    >> Share

  16. CARTER C, Shah A
    The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
    Chest. 2025;167:914-916.
    >> Share

  17. MERRELL E, Georas SN
    Is Tissue the Issue When It Comes to Severe Asthma?
    Chest. 2025;167:911-913.
    >> Share

  18. HERNANDEZ P, Bosse Y, Bush P, Chapman KR, et al
    Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice Guideline.
    Chest. 2025;167:1044-1063.
    >> Share

  19. ZHOU P, Yu W, Zhang W, Ma J, et al
    COPD-Associated Expiratory Central Airway Collapse: Current Concepts and New Perspectives.
    Chest. 2025;167:1024-1043.
    >> Share

  20. COX NS, McDonald C, Burge AT, Hill CJ, et al
    Comparison of Clinically Meaningful Improvements After Center-Based and Home-Based Telerehabilitation in People With COPD.
    Chest. 2025;167:1003-1011.
    >> Share

  21. BROCK JM, Dittrich SA, Eichhorn F, Schlamp K, et al
    Lessons Learned: Risk Factors and Clinical Impact of Severe Pneumothorax After Endoscopic Lung Volume Reduction With Endobronchial Valves.
    Chest. 2025;167:1012-1023.
    >> Share

    March 2025
  22. FREUND O, Bar-Shai A, Alkhazov A, Stav D, et al
    Bronchiectasis in patients with inflammatory bowel diseases - prevalence, predictors, and clinical characteristics.
    Chest. 2025 Mar 28:S0012-3692(25)00405-2. doi: 10.1016/j.chest.2025.
    >> Share

  23. HERMANN EA, Yang JX, Angelini E, Balte P, et al
    CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study.
    Chest. 2025 Mar 27:S0012-3692(25)00399-X. doi: 10.1016/j.chest.2025.
    >> Share

  24. CHOI H, Kwak IY, Oh CR, Goo JM, et al
    Prevalence of Airflow Limitation and Emphysema in Lung Cancer Screening Populations: A Systematic Review and Meta-analysis.
    Chest. 2025 Mar 5:S0012-3692(25)00270-3. doi: 10.1016/j.chest.2025.
    >> Share

  25. HENDERSON CJ, Lesnick BL
    Obstructive Lung Disease in Osteogenesis Imperfecta: A Potential Model for Interstitial Lung Disease, COPD, and Asthma.
    Chest. 2025;167:645-646.
    >> Share

  26. EKSTROM M, Lewthwaite H, Li PZ, Bourbeau J, et al
    Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing.
    Chest. 2025;167:697-711.
    >> Share

  27. SUISSA S, Dell'Aniello S, Ernst P
    Single-Inhaler Triple vs Long-Acting Beta(2)-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical Practice.
    Chest. 2025;167:712-723.
    >> Share

  28. PANKOVITCH S, Frohlich M, AlOthman B, Marciniuk J, et al
    Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.
    Chest. 2025;167:736-745.
    >> Share

  29. ANDERSEN JD, Lyster ML, Holst MK, Henriksen DP, et al
    Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.
    Chest. 2025;167:806-817.
    >> Share

    February 2025
  30. MOZAFFARIPOUR A, Tcherner S, McIntosh MJ, Kooner HK, et al
    Does the Reversal and Normalization of Airway and Pulmonary Vascular Remodeling Accompany Asthma Remission?
    Chest. 2025 Feb 14:S0012-3692(25)00160-6. doi: 10.1016/j.chest.2025.
    >> Share

  31. AMBROSINO P, Vitacca M, Marcuccio G, Spanevello A, et al
    A Comparison of GOLD and STAR Severity Stages in Individuals With COPD Undergoing Pulmonary Rehabilitation.
    Chest. 2025;167:387-401.
    >> Share

  32. COLLINS SE, Kirby M, Smith BM, Tan W, et al
    Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.
    Chest. 2025;167:402-413.
    >> Share

  33. CHOI JY, Lee CH, Joo H, Sim YS, et al
    Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD.
    Chest. 2025;167:414-424.
    >> Share

  34. CESTELLI L, Johannessen A, Gulsvik A, Stavem K, et al
    Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.
    Chest. 2025;167:548-560.
    >> Share

  35. SCIURBA FC, Christenson SA, Rheault T, Bengtsson T, et al
    Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD.
    Chest. 2025;167:425-435.
    >> Share

  36. COSTA FILHO FF, Buckley JD, Furlan A, Campbell S, et al
    Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States.
    Chest. 2025;167:436-443.
    >> Share

    January 2025
  37. MCCRAVY MS, Ingram JL, Que LG
    Weighing the Options: New Insights and Ongoing Challenges in Asthma With Obesity.
    Chest. 2025;167:1-2.
    >> Share

  38. MARSAA K, Guldin MB, Marques A, Pinnock H, et al
    Understanding Nonpharmacologic Palliative Care for People With Serious COPD: The Individual and Organizational Perspective.
    Chest. 2025;167:112-120.
    >> Share

  39. HARVEY-DUNSTAN TC, Baldwin MM, Tal-Singer R, Allinder M, et al
    The Responsiveness of Exercise Tests in COPD: A Randomized Controlled Trial.
    Chest. 2025;167:98-111.
    >> Share

  40. ECKHARDT CM, Wu H, Jackson G, Sobel MH, et al
    Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart Study.
    Chest. 2025;167:87-97.
    >> Share

  41. KIM DH, Jeon ET, Lee HJ, Park H, et al
    Longitudinal Changes in Maximal Forced Inspiratory Flow and Clinical Outcomes in Patients With COPD.
    Chest. 2025;167:76-86.
    >> Share

    December 2024
  42. COSIO BG, Iglesias A, Shafiek H, Mosteiro M, et al
    The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study.
    Chest. 2024 Dec 30:S0012-3692(24)05733-7. doi: 10.1016/j.chest.2024.
    >> Share

  43. CHAN R, Gochicoa-Rangel L, Cottini M, Comberiati P, et al
    Ascertainment of small airway dysfunction using oscillometry to better define asthma control and future risk: are we ready to implement it in clinical practice?
    Chest. 2024 Dec 27:S0012-3692(24)05728-3. doi: 10.1016/j.chest.2024.
    >> Share

  44. JESENAK M, Bobcakova DA, Djukanovic R, Gaga M, et al
    Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care.
    Chest. 2024 Dec 11:S0012-3692(24)05617-4. doi: 10.1016/j.chest.2024.
    >> Share

  45. BUSSE WW, Pavord ID, Wechsler ME, Davila IJ, et al
    Stability of Fractional Exhaled Nitric Oxide and its Relationship with Exacerbation in Patients Aged 6 Years or Older with Uncontrolled, Moderate-to-Severe Asthma.
    Chest. 2024 Dec 2:S0012-3692(24)05601-0. doi: 10.1016/j.chest.2024.
    >> Share

  46. JIN Z
    Further Discussion Regarding the Increased Risk of Pertussis in Populations With Asthma or COPD.
    Chest. 2024;166:e201.
    >> Share

  47. BIERBRIER J, Gerstein E, Whitmore GA, Vandemheen KL, et al
    Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis.
    Chest. 2024;166:1296-1308.
    >> Share

  48. OLENGA VUVU LOFUTA P, Klass M, Pauwen N, Kipula AM, et al
    Occupational Exposure to Charcoal Smoke and Dust, a Major Risk Factor for COPD: A Multiregional Cross-Sectional Study in the Democratic Republic of Congo.
    Chest. 2024;166:1334-1346.
    >> Share

  49. AKULA M, Nguyen M, Abraham J, Arora VM, et al
    Determining If COPD Self-Management Televisit-Based Interventions Are Evaluated Among and Equitably Effective Across Diverse Patient Populations to Reduce Acute Care Use: A Scoping Review.
    Chest. 2024;166:1371-1393.
    >> Share

    November 2024
  50. MURRAY JK, McNally E, Kent BD
    Clinical accuracy and risk of harm in asthma related content on TikTok.
    Chest. 2024 Nov 9:S0012-3692(24)05466-7. doi: 10.1016/j.chest.2024.
    >> Share

  51. KHALAF Z, Saglani S, Bloom CI
    Implementation and effectiveness of guideline-recommended clinical activities for children with asthma: population-based cohort.
    Chest. 2024 Nov 6:S0012-3692(24)05442-4. doi: 10.1016/j.chest.2024.
    >> Share

  52. CHOTIRMALL SH, Chang AB, Chalmers JD
    Infection vs Inflammation: The Bronchiectasis "Tug Of War".
    Chest. 2024;166:928-930.
    >> Share

  53. ZHUO B, Ran S, Qian AM, Zhang J, et al
    Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.
    Chest. 2024;166:975-986.
    >> Share

  54. MATHIOUDAKIS AG, Bate S, Sivapalan P, Jensen JS, et al
    Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.
    Chest. 2024;166:987-997.
    >> Share

  55. NIU Y, Niu H, Meng X, Zhu Y, et al
    Associations Between Air Pollution and the Onset of Acute Exacerbations of COPD: A Time-Stratified Case-Crossover Study in China.
    Chest. 2024;166:998-1009.
    >> Share

  56. BREMS JH, Vick J, Ashana D, Beach MC, et al
    "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
    Chest. 2024;166:1155-1161.
    >> Share

  57. METTLER SK, Nath HP, Grumley S, Orejas JL, et al
    Silent Airway Mucus Plugs in COPD and Clinical Implications.
    Chest. 2024;166:1010-1019.
    >> Share

    October 2024
  58. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    >> Share

  59. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    >> Share

  60. YANG H, Yang Y, Wang F, Miao C, et al
    Clinical and Prognostic Differences in Mild to Moderate COPD With and Without Emphysema.
    Chest. 2024 Oct 23:S0012-3692(24)05397-2. doi: 10.1016/j.chest.2024.
    >> Share

  61. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A one-year weight management programme for difficult-to-treat asthma with obesity: a randomised controlled study.
    Chest. 2024 Oct 18:S0012-3692(24)05320-0. doi: 10.1016/j.chest.2024.
    >> Share

  62. CHALMERS JD, Burgel PR, Daley CL, DE-Soyza A, et al
    TEMPORARY REMOVAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BRENSOCATIB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS - THE ASPEN TRIAL.
    Chest. 2024;166.
    >> Share

  63. JIN Z
    Does Rheumatoid Arthritis Increase the Risk of COPD?
    Chest. 2024;166:e126-e127.
    >> Share

  64. CARR TF
    The Lifelong Burden of Severe Childhood Asthma.
    Chest. 2024;166:653-654.
    >> Share

  65. ROZENBERG D, Reid WD, Camp P, Campos JL, et al
    Translating the Interplay of Cognition and Physical Performance in COPD and Interstitial Lung Disease: Meeting Report and Literature Review.
    Chest. 2024;166:721-732.
    >> Share

  66. QUINTERO SANTOFIMIO V, Knox-Brown B, Potts J, Bartlett-Pestell S, et al
    Small Airways Obstruction and Mortality: Findings From the UK Biobank.
    Chest. 2024;166:712-720.
    >> Share

    September 2024
  67. COUILLARD S, Jackson DJ, Pavord ID, Wechsler ME, et al
    How I do it. Choosing the right biologic for the right patient with severe asthma.
    Chest. 2024 Sep 6:S0012-3692(24)05139-0. doi: 10.1016/j.chest.2024.
    >> Share

    August 2024
  68. SUEN AO, Bischoff K, Iyer AS, Radhakrishnan K, et al
    Differences in Healthcare and Palliative Care Utilization at the End of Life: a Comparison Study Between Lung Cancer, COPD, and IPF.
    Chest. 2024 Aug 24:S0012-3692(24)05049-9. doi: 10.1016/j.chest.2024.
    >> Share

  69. TELLO K, Yogeswaran A, Majeed RW, Kiely DG, et al
    Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry.
    Chest. 2024 Aug 23:S0012-3692(24)05046-3. doi: 10.1016/j.chest.2024.
    >> Share

  70. COSTANTINI JG, Lo JC, Ko J, Chandra M, et al
    Ethnic Variation in Asthma Prevalence across Childhood in the Asian American and Pacific Islander Population.
    Chest. 2024 Aug 22:S0012-3692(24)04999-7. doi: 10.1016/j.chest.2024.
    >> Share

  71. WANG JM, Araki T, Cottin V, Han MK, et al
    Quantitative imaging methods in combined pulmonary fibrosis and emphysema.
    Chest. 2024 Aug 16:S0012-3692(24)04921-3. doi: 10.1016/j.chest.2024.
    >> Share

  72. RHOADS SL, Mohan A
    A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
    Chest. 2024;166:241-242.
    >> Share

  73. BREMS JH, Balasubramanian A, Raju S, Putcha N, et al
    Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations.
    Chest. 2024;166:294-303.
    >> Share

    July 2024
  74. YANG HM, Ryu MH, Carey VJ, Young K, et al
    COPD Subtypes Are Differentially Associated with Cardiovascular Events and COPD Exacerbations.
    Chest. 2024 Jul 31:S0012-3692(24)04878-5. doi: 10.1016/j.chest.2024.
    >> Share

  75. WALLSTROM O, Stridsman C, Lindberg A, Nyberg F, et al
    Exacerbation history and risk of myocardial infarction and pulmonary embolism in chronic obstructive pulmonary disease.
    Chest. 2024 Jul 31:S0012-3692(24)04880-3. doi: 10.1016/j.chest.2024.
    >> Share

  76. PATTI MA, Henderson NB, Phipatanakul W, Jackson-Browne M, et al
    Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review.
    Chest. 2024 Jul 24:S0012-3692(24)04845-1. doi: 10.1016/j.chest.2024.
    >> Share

  77. VAN GANSE E, Louis R
    International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?
    Chest. 2024;166:3-4.
    >> Share

  78. BOURBEAU J, Sin DD
    Global Initiative for Chronic Obstructive Lung Disease and Canadian Thoracic Society COPD Guidelines: Two Sides of the Same Coin or Different Coins?
    Chest. 2024;166:24-27.
    >> Share

  79. SUISSA S
    COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No.
    Chest. 2024;166:17-20.
    >> Share

  80. ADRISH M, Hanania NA
    POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes.
    Chest. 2024;166:12-17.
    >> Share

  81. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
    Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation.
    Chest. 2024;166:81-94.
    >> Share

    June 2024
  82. SAVRAN O, Bonnelykke K, Ulrik CS
    Characteristics of adults with severe asthma in childhood - A 60-year Follow-up Study.
    Chest. 2024 Jun 28:S0012-3692(24)00806-7. doi: 10.1016/j.chest.2024.
    >> Share

  83. EWEN R, Pink I, Sutharsan S, Aries SP, et al
    Primary Ciliary Dyskinesia in Adult Bronchiectasis - Data from the German Bronchiectasis Registry PROGNOSIS.
    Chest. 2024 Jun 14:S0012-3692(24)00703-7. doi: 10.1016/j.chest.2024.
    >> Share

  84. SATICI C, Bek EO
    The Role of Electronic Nose Analysis of Exhaled Air in Detection of Lung Cancer Among Patients With COPD.
    Chest. 2024;165:e201.
    >> Share

  85. ROSSIDES M
    Rheumatoid Arthritis and COPD: Thinking Beyond Smoking.
    Chest. 2024;165:1278-1279.
    >> Share

  86. MCDERMOTT GC, Sparks JA
    Rheumatoid Arthritis and Bronchiectasis Risk: Additional Evidence Linking Autoimmunity and Airways Disease.
    Chest. 2024;165:1276-1277.
    >> Share

  87. FARMER MJS, Callahan CD, Hughes AM, Riska KL, et al
    Applying Noninvasive Ventilation in Treatment of Acute Exacerbation of COPD Using Evidence-Based Interprofessional Clinical Practice.
    Chest. 2024;165:1469-1480.
    >> Share

  88. CHUNG C, Kim H, Han K, Jung J, et al
    Does Rheumatoid Arthritis Increase the Risk of COPD?: A Nationwide Retrospective Cohort Study.
    Chest. 2024;165:1362-1371.
    >> Share

  89. KAMINSKA M, Adam V, Orr JE
    Home Noninvasive Ventilation in COPD.
    Chest. 2024;165:1372-1379.
    >> Share

    May 2024
  90. TAN DJ, van Geffen WH, Walters EH
    Impact of Triple Therapy vs Dual Bronchodilator Therapy on Mortality Rates in COPD.
    Chest. 2024;165:e158-e159.
    >> Share

  91. WU WW, Wang G
    How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Chest. 2024;165:e157-e158.
    >> Share

  92. JOHNSON KM, Duan KI
    The Growing Burden of COPD in the United States.
    Chest. 2024;165:1027-1028.
    >> Share

  93. MANNINO DM, Roberts MH, Mapel DW, Zhang Q, et al
    National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Chest. 2024;165:1093-1106.
    >> Share

    April 2024
  94. LEE H, Moon JY, Min KH
    Real-World Clinical Studies to Understand the Current Status and Future Improvements of Pulmonary Rehabilitation in Chronic Lung Diseases.
    Chest. 2024;165:e125.
    >> Share

  95. ASH SY
    Quantitative Imaging and Bronchial Thermoplasty: Technically Impressive But Clinically Uncertain.
    Chest. 2024;165:755-756.
    >> Share

  96. SAMANT M, Krings JG, Lew D, Goss CW, et al
    Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
    Chest. 2024;165:775-784.
    >> Share

  97. RYU MH, Murphy S, Hinkley M, Carlsten C, et al
    COPD Exposed to Air Pollution: A Path to Understand and Protect a Susceptible Population.
    Chest. 2024;165:836-846.
    >> Share

  98. ARON J, Baldomero AK, Rau A, Fiecas MB, et al
    Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban Patients With COPD.
    Chest. 2024;165:825-835.
    >> Share

    March 2024
  99. GUPTA S, Couillard S, Digby G, Tse SM, et al
    Climate Change and Inhaler Selection in Patients With Respiratory Disease.
    Chest. 2024;165:503-506.
    >> Share

  100. SAHAY S
    Rebuttal From Dr Sahay.
    Chest. 2024;165:498-499.
    >> Share

  101. BINEY IN, Ari A, Barjaktarevic IZ, Carlin B, et al
    Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
    Chest. 2024;165:653-668.
    >> Share

  102. HE D, Yan M, Zhou Y, Ge H, et al
    Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
    Chest. 2024;165:573-582.
    >> Share

    February 2024
  103. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
    Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
    Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
    >> Share

  104. LEE TY, Price D, Yadav CP, Roy R, et al
    International variation in severe exacerbation rates in patients with severe asthma.
    Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016